JPET

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


Journal of Pharmacology And Experimental Therapeutics Fast Forward
First published on June 30, 2008; DOI: 10.1124/jpet.108.140889


0022-3565/08/3271-10-19$20.00
JPET 327:10-19, 2008
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
jpet.108.140889v1
327/1/10    most recent
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Guo, A. M.
Right arrow Articles by Scicli, A. G.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Guo, A. M.
Right arrow Articles by Scicli, A. G.

CELLULAR AND MOLECULAR

Expression of CYP4A1 in U251 Human Glioma Cell Induces Hyperproliferative Phenotype in Vitro and Rapidly Growing Tumors in Vivo

Austin M. Guo, Ju Sheng, Gloria M. Scicli, Ali S. Arbab, Norman L. Lehman, Paul A. Edwards, John R. Falck, Richard J. Roman, and A. Guillermo Scicli

Henry Ford Hospital, Detroit, Michigan (A.M.G., J.S., G.M.S., A.S.A., N.L.L., P.A.E., A.G.S.); University of Texas Southwestern Medical Center, Dallas, Texas (J.R.F.); Medical College of Wisconsin, Milwaukee, Wisconsin (R.J.R.); and Henry Ford Hospital and Wayne State University, Detroit, Michigan (A.G.S.)

Exogenous 20-hydroxyeicosatetraenoic acid (20-HETE) increases the growth of human glioma cells in vitro. However, glioma cells in culture show negligible 20-HETE synthesis. We examined whether inducing the expression of a 20-HETE synthase in a human glioma U251 cell line would increase proliferation. U251 cells transfected with CYP4A1 cDNA (termed U251 O) increased the formation of 20-HETE from less than 1 to over 60 pmol/min/mg proteins and increased their proliferation rate by 2-fold (p < 0.01). Compared with control U251, U251 O cells were rounded, smaller, showed a disorganized cytoskeleton, exhibited reduced vinculin staining, and were easily detached from the growing surface. They showed a marked increase in dihydroethidium staining, suggesting increased oxidative stress. The expression of phosphorylated extracellular signal-regulated kinase 1/2, cyclin D1/2, and vascular endothelial growth factor was markedly elevated in U251 O. The hyperproliferative and signaling effects seen in U251 O cells are abolished by selective CYP4A inhibition of 20-HETE formation with HET0016 [N-hydroxy-N'-(4-butyl-2-methylphenyl)-formamidine], by small interfering RNA against the enzyme, and by the putative 20-HETE antagonist, 20-hydroxyeicosa-5(Z),14(Z)-dienoic acid. In vivo, implantation of U251O cells in the brain of nude rats resulted in a ~10-fold larger tumor volume (10 days postimplantation) compared with animals receiving mock-transfected U251 cells. These data show that elevations in 20-HETE synthesis in U251 cells lead to an increased growth both in vitro and in vivo. This suggests that 20-HETE may have proto-oncogenic properties in U251 human gliomas. Further studies are needed to determine whether 20-HETE plays a role promoting growth of some human gliomas.


Received for publication May 13, 2008
Accepted June 27, 2008.

Address correspondence to: Dr. Austin M. Guo, Eye Care Services, Henry Ford Health System, One Ford Place, 4 D, Detroit, MI 48202-3450. E-mail: mguo1{at}hfhs.org




This article has been cited by other articles:


Home page
Am. J. Physiol. Renal Physiol.Home page
T. Akbulut, K. R. Regner, R. J. Roman, E. D. Avner, J. R. Falck, and F. Park
20-HETE activates the Raf/MEK/ERK pathway in renal epithelial cells through an EGFR- and c-Src-dependent mechanism
Am J Physiol Renal Physiol, September 1, 2009; 297(3): F662 - F670.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
A. M. Guo, G. Scicli, J. Sheng, J. C. Falck, P. A. Edwards, and A. G. Scicli
20-HETE can act as a nonhypoxic regulator of HIF-1{alpha} in human microvascular endothelial cells
Am J Physiol Heart Circ Physiol, August 1, 2009; 297(2): H602 - H613.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
S. Xu, Y. He, M. Vokurkova, and R. M. Touyz
Endothelial Cells Negatively Modulate Reactive Oxygen Species Generation in Vascular Smooth Muscle Cells: Role of Thioredoxin
Hypertension, August 1, 2009; 54(2): 427 - 433.
[Abstract] [Full Text] [PDF]




Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 2008 by the American Society for Pharmacology and Experimental Therapeutics.